Topics
- Partnering with Global Investigative Sites
- How Companies are Re-Thinking Global Clinical Trials
- Regulatory Update on Global Clinical Trials and in particular Emerging Markets
- Lessons Learned from Unsuccessful Global Clinical Trials
- Risk Based Monitoring for Global Clinical Trials
- CRO Best Practices in Collaborations, Implementation and Execution of Multi-National Trials:
- Designing Patient-Centric Protocols to Increase Global Patient Engagement
- Technologies Driving Efficiencies in Global Clinical Trials
- Re-Thinking Global Patient Recruitment and the Patient Experience in Global Clinical Trials
- Reducing Protocol Complexity
- Trends of Approvals Outside the US
- Audit Inspections Update
Who should Attend
Biotech and pharmaceutical senior executives with responsibilities in:
- Clinical Research & Development
- Global Clinical Operations
- Clinical Project Management
- Clinical Outsourcing
- Clinical Strategy
- Clinical Design
- Patient Recruitment/Enrollment
- Biostatistics
- Investigators
- Medical Directors
- Protocol Design
- Ethics
- Regulatory Affairs
- Distribution
and CROs, Patient Recruitment, and Logistic and Translation companies.
